Evidence map›Paper›PMID 36751416›Full record

ArticleJBMR plus2023

Downregulation of the Autism Spectrum Disorder Gene

Mubashir Ahmad, Nadine Stirmlinger, Irfana Jan, Ulrich Stifel, Sooyeon Lee, Marcel Weingandt, Ulrike Kelp, Jürgen Bockmann, Anita Ignatius, Tobias M Böckers and 1 more

Open access · goldAbstract read
In one paragraph

Article in JBMR plus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Mubashir AhmadInstitute of Comparative Molecular Endocrinology (CME) Ulm University Ulm Germany.ORCID https://orcid.org/0000-0001-9012-4039
Nadine StirmlingerInstitute for Anatomy and Cell Biology Ulm University Ulm Germany.
Irfana JanInstitute of Comparative Molecular Endocrinology (CME) Ulm University Ulm Germany.
Ulrich StifelInstitute of Comparative Molecular Endocrinology (CME) Ulm University Ulm Germany.
Sooyeon LeeInstitute of Comparative Molecular Endocrinology (CME) Ulm University Ulm Germany.
Marcel WeingandtInstitute of Comparative Molecular Endocrinology (CME) Ulm University Ulm Germany.
Ulrike KelpInstitute of Comparative Molecular Endocrinology (CME) Ulm University Ulm Germany.
Jürgen BockmannInstitute for Anatomy and Cell Biology Ulm University Ulm Germany.
Anita IgnatiusInstitute of Orthopaedic Research and Biomechanics Ulm University Ulm Germany.
Tobias M BöckersInstitute for Anatomy and Cell Biology Ulm University Ulm Germany.
Jan TuckermannInstitute of Comparative Molecular Endocrinology (CME) Ulm University Ulm Germany.ORCID https://orcid.org/0000-0003-3691-275X
Universität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations of the postsynaptic scaffold protein Shank2 lead to autism spectrum disorders (ASD). These patients frequently suffer from higher fracture risk. Here, we investigated whether Shank2 directly regulates bone mass. We show that Shank2 is expressed in bone and that Shank2 levels are increased during osteoblastogenesis. Knockdown of Shank2 by siRNA targeting the encoding regions for

Indexed as

BONE MASSOSTEOBLAST DIFFERENTIATIONSHANK2

Identifiers

PMID36751416
PMCPMC9893268
OpenAlexW4312194436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.